References
All links accessed on September 29th 2024
1.NICE guideline NG87. ‘Attention deficit hyperactivity disorder: diagnosis and management’. Published March 14 2018, last updated September 13 2019 https://www.nice.org.uk/guidance/ng87
2. DSM-5 Changes: Implications for Child Serious Emotional Disturbance Internet. Table 7, DSM-IV to DSM-5 Attention-Deficit/Hyperactivity Disorder Comparison. Substance Abuse and Mental Health Services Administration (US) Rockville (MD). June 2016. https://www.ncbi.nlm.nih.gov/books/NBK519712/table/ch3.t3/
3. ICD-11 for Mortality and Morbidity Statistics 2024-01. 6A05 Attention deficit hyperactivity disorder. https://icd.who.int/browse/2024-01/mms/en#821852937
4. NHS England. Attention deficit hyperactivity disorder (ADHD) Programme update. Agenda item 6. March 28 2024. https://www.england.nhs.uk/long-read/attention-deficit-hyperactivity-disorder-adhd-programme-update/
5. A Russo. ‘ADD vs. ADHD Symptoms: 3 Types of Attention Deficit Disorder’. Additude. September 4 2019. https://www.additudemag.com/add-adhd-symptoms-difference/
6. Cleveland Clinic. Attention-Deficit/Hyperactivity Disorder (ADHD). Last reviewed February 22 2023. https://my.clevelandclinic.org/health/diseases/4784-attention-deficithyperactivity-disorder-adhd
7. K Sayal at al. ‘ADHD in children and young people: prevalence, care pathways & service provision’. Lancet Psychiatry. February 2017. 5;2:175-186. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(17)30167-0/abstract
8. ADHD UK. ADHD Incidence. https://adhduk.co.uk/adhd-incidence/
9. National Institute for Health and Care Research (NIHR). ‘Significant rise in ADHD diagnoses in the UK’. July 18 2023. https://www.nihr.ac.uk/about-us/news/significant-rise-adhd-diagnoses-uk
10. DGJ McKechnie et al. ‘Attention-deficit hyperactivity disorder diagnoses and prescriptions in UK primary care, 2000–2018: population-based cohort study’. BJPsych Open. 2023. 9;4:e121. https://www.cambridge.org/core/journals/bjpsych-open/article/attentiondeficit-hyperactivity-disorder-diagnoses-and-prescriptions-in-uk-primary-care-20002018-populationbased-cohort-study/E0818CCAE895FF273C7448756CFB0066
11. BS da Silva et al. ‘An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder’. Discov Ment Health. January 5 2023. 3;2. https://link.springer.com/article/10.1007/s44192-022-00030-1
12. NHS health A to Z. Attention deficit hyperactivity disorder (ADHD). Last reviewed December 24 2021. https://www.nhs.uk/conditions/attention-deficit-hyperactivity-disorder-adhd/
13. MHRA. Drug Safety Update. ‘Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations’. September 26 2022. https://www.gov.uk/drug-safety-update/methylphenidate-long-acting-modified-release-preparations-caution-if-switching-between-products-due-to-differences-in-formulations
14. emc – electronic medicinews compendium. Summaries of Product Characteristics. https://www.medicines.org.uk/emc
15. NICE BNF. Lisdexamfetamine mesylate. https://bnf.nice.org.uk/drugs/lisdexamfetamine-mesilate/
16. ADHD Aware. Treatment options for adults. https://adhdaware.org.uk/what-is-adhd/medications/